Skip Ribbon Commands
Skip to main content
Navigate Up
Sign In
 
 

 Latest News

 
8/28/2015
​Corticosteroids are widely used as a treatment for uveitis, but their long-term use is known to be associated with a wide variety of adverse events. Pharmerit conducted a systematic
8/20/2015
Patricia Benton, a senior finance executive, has joined Pharmerit International as Chief Financial Officer, managing partners Jennifer Stephens and Lex Tergau announced today.
8/13/2015
In this report we evaluated the published studies and argue that acute hyperglycaemia is worth investigating in relation to the real-life implications.
7/23/2015
This study reassess the costs and effects of photoselective vaporization of the prostate (PVP) versus transurethral resection of the prostate (TURP) on the basis of most recent data.
7/9/2015
​Coronary heart disease (CHD) is a major public health concern; it is the leading cause of mortality worldwide, accounting for more than 7 million deaths each year.
7/2/2015
The study presents a cost-effective treatment option for patients with chronic genotype 1 HCV infection
7/2/2015
​A systematic literature review was conducted to provide an overview of published literature in the last 10-years.
7/2/2015
The model allows patients to move through a treatment sequence with treatment response measured via ACR criteria
4/14/2015
ISPOR and Value in Health, journal for research that advance the field of pharmacogenomics and outcomes research, endorse Pharmerit’s academic research on reimbursement in Scotland.
4/10/2015
Type 2 diabetes mellitus is estimated to account for 7–12% of the UK National Health Service expenditure. Economic analysis is critical to ensuring that limited resources are used effectively.
Contact Feel free to contact us if you have any questions